Author:
Jiang Xianjie,Wang Jie,Deng Xiangying,Xiong Fang,Ge Junshang,Xiang Bo,Wu Xu,Ma Jian,Zhou Ming,Li Xiaoling,Li Yong,Li Guiyuan,Xiong Wei,Guo Can,Zeng Zhaoyang
Funder
Overseas Expertise Introduction Project for Discipline Innovation 111 Project
National Natural Science Foundation of China
the Natural Science Foundation of Hunan Province
Natural Science Foundation of Hunan Province
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine
Reference178 articles.
1. Jiang XJ, Wang J, Deng XY, Li XL, Li XY, Zeng ZY, et al. Immunotherapy targeted to immune checkpoint: a revolutionary breakthrough in cancer therapy. Prog Biochem Biophys. 2018;45(11):1178–86.
2. Jiang X, Shapiro DJ. The immune system and inflammation in breast cancer. Mol Cell Endocrinol. 2014;382(1):673–82.
3. Wang YA, Li XL, Mo YZ, Fan CM, Tang L, Xiong F, et al. Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer. 2018;17(1):168.
4. Yu J, Du W, Yan F, Wang Y, Li H, Cao S, et al. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J Immunol. 2013;190(7):3783–97.
5. Benencia F, Muccioli M, Alnaeeli M. Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies. Front Oncol. 2014;4:72.
Cited by
969 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献